Financials

News Discussions Technicals Forecast Seasonals

CTNM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Contineum Therapeutics, Inc. operating, investing, and financing activities

CTNM free cash flow for Q1 25 is -14.46 M USD. For 2024, CTNM free cash flow was -33.36 M USD and operating cash flow was -32.84 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—